About William Hoh

William Hoh, MS
Board Vice Chair
Managing Director of M&A and Strategic Advisory Services: H.C. Wainwright

William Hoh is a Managing Director in the M&A and Strategic Advisory Services Group at H.C. Wainwright. He has over 25 years of healthcare experience in investment banking, asset management, and venture capital.  

Prior to joining Wainwright, Mr. Hoh was a Managing Director at T.R. Winston & Company and previous to that, he founded Goldwater Management, an investment, consulting and strategic advisory firm which specializes in global health care. Mr. Hoh has over sixteen years of direct investing experience managing portfolios at top institutions including Soros and SAC Capital. In addition, Mr. Hoh has over fifteen years of experience investing and advising clients in China health care. He was also Venture Partner at 3E Bioventures, a China-based health care venture capital firm.

Mr. Hoh serves as a member of the Board of Trustees of the Huntington Study Group, a non-profit dedicated to seeking treatments that make a difference in Huntington’s disease. He holds a BS in Biology and Philosophy from the University of Michigan and an MS in Physiology at Georgetown University.